Pfizer Inc. and BioNTech SE submitted initial trial data for their COVID-19 vaccine in children aged 5 to 11 to U.S. regulators on Tuesday and said they would make a formal request for emergency use authorization in the coming weeks.
source https://www.cbc.ca/news/health/pfizer-biontech-us-fda-covid-vaccine-children-1.6191807?cmp=rss
No comments:
Post a Comment